
Expanding access and method choice: Evidence of client self-administration of injectables and private sector provision of family planning services in three West African countries
Author(s) -
AUTHOR_ID
Publication year - 2020
Language(s) - English
Resource type - Reports
DOI - 10.31899/sbsr2020.1003
Subject(s) - general partnership , business , family planning , context (archaeology) , developing country , economic growth , pharmacy , service delivery framework , service provider , access to medicines , private sector , service (business) , marketing , population , medicine , geography , finance , environmental health , economics , family medicine , research methodology , archaeology
Governments across West Africa have expressed their commitment to increasing access to voluntary family planning (FP) through global and regional initiatives such as FP2020 and the Ouagadougou Partnership, and through targeted national strategies. Ghana, Nigeria and Senegal, among other countries, have been exploring new strategies to expand access to voluntary FP service delivery. Context-specific evidence was needed for two promising strategies—1) task sharing of FP services to private sector drug shops and pharmacies, and 2) introducing self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC). The Evidence Project collaborated with stakeholders in Ghana, Nigeria, and Senegal to use implementation science (IS) to expand the evidence base on these promising approaches. In this brief, we describe key study results from the three countries and how results have been used to increase access to voluntary family planning and expand method choice.